Overview
Ovarian cancer is any cancerous growth that may occur in
different parts of the ovary. The majority of ovarian cancers arise from the
epithelium (outer lining) of the ovary. Signs and symptoms of ovarian cancer
include pelvic discomfort or pain, indigestion, gas or nausea, changes in bowel
habits, such as constipation, loss of appetite and low back pain. The
predisposing factors include age and family history. Treatment includes
surgery, chemotherapy and radiation therapy.
Click here for sample report @ http://www.wiseguyreports.com/sample-request/1555340-ovarian-cancer-pipeline-review-h1-2017
Report
Highlights
The Pharmaceutical and Healthcare latest pipeline guide
Ovarian Cancer - Pipeline Review, H1 2017, provides comprehensive information
on the therapeutics under development for Ovarian Cancer (Oncology), complete
with analysis by stage of development, drug target, mechanism of action (MoA),
route of administration (RoA) and molecule type. The guide covers the
descriptive pharmacological action of the therapeutics, its complete research
and development history and latest news and press releases.
The Ovarian Cancer (Oncology) pipeline guide also reviews of
key players involved in therapeutic development for Ovarian Cancer and features
dormant and discontinued projects. The guide covers therapeutics under Development
by Companies /Universities /Institutes, the molecules developed by Companies in
Pre-Registration, Filing rejected/Withdrawn, Phase III, Phase II, Phase I,
IND/CTA Filed, Preclinical, Discovery and Unknown stages are 4, 2, 15, 135,
128, 7, 208, 21 and 5 respectively. Similarly, the Universities portfolio in
Phase II, Phase I, Preclinical and Discovery stages comprises 11, 14, 43 and 8
molecules, respectively.
Major Scope of the report:
- The pipeline guide provides a snapshot of the global
therapeutic landscape of Ovarian Cancer (Oncology).
- The pipeline guide reviews pipeline therapeutics for Ovarian Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Ovarian Cancer (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide reviews pipeline therapeutics for Ovarian Cancer (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Ovarian Cancer (Oncology) therapeutics and enlists all their major and minor projects.
Table of Contents
Table of Contents 2
Introduction 12
Ovarian Cancer - Overview 13
Ovarian Cancer - Therapeutics Development 14
Ovarian Cancer - Therapeutics Assessment 73
Ovarian Cancer - Companies Involved in Therapeutics Development 105
Ovarian Cancer - Drug Profiles 254
Ovarian Cancer - Dormant Projects 1928
Ovarian Cancer - Discontinued Products 1947
Ovarian Cancer - Product Development Milestones 1951
Appendix 1968
Introduction 12
Ovarian Cancer - Overview 13
Ovarian Cancer - Therapeutics Development 14
Ovarian Cancer - Therapeutics Assessment 73
Ovarian Cancer - Companies Involved in Therapeutics Development 105
Ovarian Cancer - Drug Profiles 254
Ovarian Cancer - Dormant Projects 1928
Ovarian Cancer - Discontinued Products 1947
Ovarian Cancer - Product Development Milestones 1951
Appendix 1968
.Continued
For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1555340-ovarian-cancer-pipeline-review-h1-2017
About Us
Wise Guy
Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium
progressive statistical surveying, market research reports, analysis &
forecast data for industries and governments around the globe. Wise Guy Reports
understand how essential statistical surveying information is for your
organization or association. Therefore, we have associated with the top
publishers and research firms all specialized in specific domains, ensuring you
will receive the most reliable and up to date research data available.
Contact Us:
NORAH TRENT
Partner
Relations & Marketing Manager
Ph:
+1-646-845-9349 (US)
Ph: +44 208
133 9349 (UK)
